Abstract:ABSTRACT Avilamycins, which possess potent inhibitory activity against Gram-positive bacteria, are a group of oligosaccharide antibiotics produced by Streptomyces viridochromogenes . Among these structurally related oligosaccharide antibiotics, avilamycin A serves as the main bioactive component in veterinary drugs and animal feed additives, which differs from avilamycin C only in the redox state of the two-carbon branched-chain of the terminal octose moiety. However, the mechanisms underlying assembly and modification of the oligosaccharide chain to diversify individual avilamycins remain poorly understood. Here, we report that AviZ1, an aldo-keto reductase in the avilamycin pathway, can catalyze the redox conversion between avilamycins A and C . Remarkably, the ratio of these two components produced by AviZ1 depends on the utilization of specific redox cofactors, namely NADH/NAD + or NADPH/NADP + . These findings are inspired by gene disruption and complementation experiments and are further supported by in vitro enzymatic activity assays, kinetic analyses, and cofactor affinity studies on AviZ1-catalyzed redox reactions. Additionally, the results from sequence analysis, structure prediction, and site-directed mutagenesis of AviZ1 validate it as an NADH/NAD + -favored aldo-keto reductase that primarily oxidizes avilamycin C to form avilamycin A by utilizing abundant NAD + in vivo . Building upon the biological function and catalytic activity of AviZ1, overexpressing AviZ1 in S. viridochromogenes is thus effective to improve the yield and proportion of avilamycin A in the fermentation profile of avilamycins. This study represents, to our knowledge, the first characterization of biochemical reactions involved in avilamycin biosynthesis and contributes to the construction of high-performance strains with industrial value. IMPORTANCE Avilamycins are a group of oligosaccharide antibiotics produced by Streptomyces viridochromogenes , which can be used as veterinary drugs and animal feed additives. Avilamycin A is the most bioactive component, differing from avilamycin C only in the redox state of the two-carbon branched-chain of the terminal octose moiety. Currently, the biosynthetic pathway of avilamycins is not clear. Here, we report that AviZ1, an aldo-keto reductase in the avilamycin pathway, can catalyze the redox conversion between avilamycins A and C . More importantly, AviZ1 exhibits a unique NADH/NAD + preference, allowing it to efficiently catalyze the oxidation of avilamycin C to form avilamycin A using abundant NAD + in cells. Thus, overexpressing AviZ1 in S. viridochromogenes is effective to improve the yield and proportion of avilamycin A in the fermentation profile of avilamycins. This study serves as an enzymological guide for rational strain design, and the resulting high-performance strains have significant industrial value.

Alternative Epimerization in C7N-Aminocyclitol Biosynthesis Is Catalyzed by ValD, A Large Protein of the Vicinal Oxygen Chelate Superfamily

Valc, A New Type of C7-Cyclitol Kinase Involved in the Biosynthesis of the Antifungal Agent Validamycin A

Structural And Functional Analysis Of Validoxylamine A 7 '-Phosphate Synthase Vall Involved In Validamycin A Biosynthesis

Synthesis Of 5-Epi-[6-H-2(2)]Valiolone And Stereospecifically Monodeuterated 5-Epi-Valiolones: Exploring The Steric Course Of 5-Epi-Valiolone Dehydratase In Validamycin A Biosynthesis

Functional analysis of the validamycin biosynthetic gene cluster and engineered production of validoxylamine A.

Diastereospecific epoxidation and highly regioselective ring-opening of (+)-valienamine: Practical synthesis of (+)-valiolamine

Nucleotidylation of Unsaturated Carbasugar in Validamycin Biosynthesis

Gene cluster responsible for validamycin biosynthesis in Streptomyces hygroscopicus subsp. jinggangensis 5008.

Gene Cluster Responsible for Validamycin Biosynthesis in <i>Streptomyces hygroscopicus</i> subsp. <i>jinggangensis</i> 5008

Catalytic Analysis of the Validamycin Glycosyltransferase (valg) and Enzymatic Production of 4''-Epi-validamycin A.

Analysis of the Valgamicin Biosynthetic Pathway Reveals a General Mechanism for Cyclopropanol Formation across Diverse Natural Product Scaffolds

A Validamycin Shunt Pathway for Valienamine Synthesis in Engineered Streptomyces Hygroscopicus 5008

De Novo Biosynthesis of Β-Valienamine in Engineered Streptomyces Hygroscopicus 5008

Characterization of a LanC-free Pathway for the Formation of an LL-MeLan Residue and an Alloavimecys Residue in the Newly Identified Class V Lanthipeptide Triantimycins

Positive and negative regulation of GlnR in validamycin A biosynthesis by binding to different loci in promoter region

Characterization of a LanC-free pathway for the formation of an LL-MeLan residue and an allo AviMeCys residue in the newly identified class V lanthipeptide triantimycins

A vitamin K-dependent carboxylase orthologue is involved in antibiotic biosynthesis

AvmM catalyses macrocyclization through dehydration/Michael-type addition in alchivemycin A biosynthesis

Characterization of the FMN-Dependent Cysteine Decarboxylase from Thioviridamide Biosynthesis

Genetically Engineered Production of 1,1′-Bis-valienamine and Validienamycin in Streptomyces Hygroscopicus and Their Conversion to Valienamine

An NADH/NAD+-favored aldo-keto reductase facilitates avilamycin A biosynthesis by primarily catalyzing oxidation of avilamycin C